News Conference News SCAI 2024 Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows L.A. McKeown May 06, 2024
News Conference News VIVA 2023 PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI L.A. McKeown November 01, 2023
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Conference News AXIOMATIC-TKR: Milvexian Promising for VTE Prevention L.A. McKeown November 15, 2021
News Conference News TCT 2020 FlowTriever Looks Good for Acute PE in Interim FLASH Results Todd Neale October 18, 2020
News Conference News VIVA 2019 Future Pulmonary Embolism Interventions: Wild West or Working Together? L.A. McKeown November 14, 2019
News Opinion Off Script Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty Sahil Parikh, MD July 29, 2019
News Industry News Spectranetics Announces FDA Submission of Bridge(TM) Occlusion Balloon for Lead Extraction Procedures December 08, 2015
News Daily News Un Estudio de Imágenes ‘Punto de Referencia’ Socava la Hipótesis de las Anomalías Venosas en la EM October 11, 2013
Presentation VEINS 2013 New Innovations in Venous Disease Presenter: Steven R. Bailey September 20, 2013
News Daily News Un estudio refuta la hipótesis venosa en esclerosis múltiple, restándole valor al argumento del procedimiento de stents L.A. McKeown March 06, 2012
News Daily News Study Refutes Venous Hypothesis in Multiple Sclerosis, Weakening Argument for Stenting L.A. McKeown March 06, 2012